|
You all have me very confused. Let me see if I understand: statistically are you saying that HER2+ER-PR- relapses long term less than HER2+ER+PR- breast cancers? Or is it the other way around?
After reading posts for the last week or so, I started to worry about lower back pain I have been experiencing for the last few months. Have not had blood work since last November so have no indication if tumor marker is up. My oncologist is scheduling me for a bone scan asap. This is not the way I wanted to get Herceptin (not eligible before). Hope it's just old age catching up with me. Keep fingers crossed. Stephanie
|